All Pharma News
Baudax Bio Announces Corporate Update

Baudax Bio Announces Corporate Update
GLOBENEWSWIRE
18 Oct 2023
Share Share
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168

Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168
GLOBENEWSWIRE
28 Sep 2023
Share Share
Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference

Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference
GLOBENEWSWIRE
07 Sep 2023
Share Share
Baudax Announces Distribution of Series C Preferred Stock to Holders of Stock

Baudax Announces Distribution of Series C Preferred Stock to Holders of Stock
GLOBENEWSWIRE
23 Aug 2023
Share Share
Baudax Bio Announces $1.9M Registered Direct Offering Priced under Nasdaq Rules

Baudax Bio Announces $1.9M Registered Direct Offering Priced under Nasdaq Rules
GLOBENEWSWIRE
17 Aug 2023
Share Share
Baudax Bio Reports Second Quarter 2023 Financial Results

Baudax Bio Reports Second Quarter 2023 Financial Results
GLOBENEWSWIRE
16 Aug 2023
Share Share
Baudax Bio Acquires TeraImmune, Inc.

Baudax Bio Acquires TeraImmune, Inc.
GLOBENEWSWIRE
30 Jun 2023
Share Share
Baudax Bio reports promising additional data for neuromuscular blockade agent

Baudax Bio reports promising additional data for neuromuscular blockade agent
CLINICAL TRIALS ARENA
07 Jun 2023
Share Share
Baudax Bio Announces Results From Phase 2 Randomized Clinical Trial of BX1000

Baudax Bio Announces Results From Phase 2 Randomized Clinical Trial of BX1000
GLOBENEWSWIRE
07 Jun 2023
Share Share
Baudax Bio Announces Date of Reconvened Annual Meeting

Baudax Bio Announces Date of Reconvened Annual Meeting
GLOBENEWSWIRE
06 Jun 2023
Share Share